Phytoestrogens: Perpetrators Or Protectors?

• WHO report diet, nutrition, and the prevention of chronic diseases. Report of a WHO Study Group. Geneva, World Health Organisation, (WHO Technical Report Series, No. 797) (1990).
   Google Scholar
• Branca F , LorenzettiS: Health effects of phytoestrogens.Forum Nutr.57, 100–111 (2005).
   PubMedGoogle Scholar
• Bazzano LA , SerdulaMK, LiuS: Dietary intake of fruits and vegetables and risk of cardiovascular disease.Curr. Atheroscler. Rep.5, 492–499 (2003).
   PubMed Web of Science ®Google Scholar
• Montonen J , JarvinenR, HeliovaaraM, ReunanenA, AromaaA, KnektP: Food consumption and the incidence of type II diabetes mellitus.Eur. J. Clin. Nutr.59, 441–448 (2005).
   PubMed Web of Science ®Google Scholar
• He FJ , NowsonCA, MacGregorGA: Fruit and vegetable consumption and stroke: meta-analysis of cohort studies.Lancet367, 320–326 (2006).
   PubMed Web of Science ®Google Scholar
• Cline JM , HughesCLJr Phytochemicals for the prevention of breast and endometrial cancer. Cancer Treat. Rev.94, 107–134 (1998).
   Google Scholar
• Schmitz-Drager BJ , EichholzerM, BeicheB, EbertT: Nutrition and prostate cancer.Urol. Int.67, 1–11 (2001).
   PubMed Web of Science ®Google Scholar
• Adlercreutz H : Western diet and Western diseases: some hormonal and biochemical mechanisms and associations.Scand. J. Clin. Lab. Invest. Suppl.201, 3–23 (1990).
   PubMedGoogle Scholar
• Sasco AJ : Epidemiology of breast cancer: an environmental disease?APMIS109, 321–332 (2001).
   PubMed Web of Science ®Google Scholar
• Limer JL , SpeirsV: Phyto-oestrogens and breast cancer chemoprevention.Breast Cancer Res.6, 119–127 (2004).
   PubMed Web of Science ®Google Scholar
• Castle EP , ThrasherJB: The role of soy phytoestrogens in prostate cancer.Urol. Clin. North Am.29, 71–81 (2002).
   PubMed Web of Science ®Google Scholar
• Murata M , MidorikawaK, KohM, UmezawaK, KawanishiS: Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen sensitive organs.Biochemistry43, 2569–2577 (2004).
   PubMed Web of Science ®Google Scholar
• Dixon RA : Phytoestrogens.Annu. Rev. Plant. Biol.55, 225–261 (2004).
   PubMed Web of Science ®Google Scholar
• Macura B , SliwaL: Phytoestrogens: are they really safe?Folia Med. Cracov.45, 121–129 (2004).
   PubMedGoogle Scholar
• Zand RS , JenkinsDJ, DiamandisEP: Steroid hormone activity of flavonoids and related compounds.Breast Cancer Res. Treat.62, 35–49 (2000).
   PubMed Web of Science ®Google Scholar
• Benassayar C , Perrot-ApplanatM, FerreF: Phytoestrogens as modulators of steroid action in target cells.J. Chromatogr.B777, 233–248 (2002).
   Google Scholar
• Harris DM , BesselinkE, HenningSM, GoVL, HeberD: Phytoestrogens induce differential estrogen receptor α- or β-mediated responses in transfected breast cancer cells. Exp. Biol. Med.230, 558–568 (2005).
   PubMed Web of Science ®Google Scholar
• Pike AC , BrzozowskiAM, HubbardREet al.: Structure of the ligand-binding domain of oestrogen receptor b in the presence of a partial agonist and a full antagonist. EMBO J.18, 4608–4618 (1999).
   PubMed Web of Science ®Google Scholar
• Kuiper GG , CarlssonB, GrandienKet al.: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors a and b. Endocrinology138, 863–870 (1997).
   PubMed Web of Science ®Google Scholar
• Milligan SR , KalitaJC, PocockVet al.: The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. J. Clin. Endocrinol. Metab.854912–4915 (2000).
   PubMed Web of Science ®Google Scholar
• Miksicek RJ : Estrogenic flavonoids: structural requirements for biological activity.Proc. Soc. Exp. Biol. Med.208, 44–50 (1995).
   PubMed Web of Science ®Google Scholar
• Kirk CJ , HarrisRM, WoodDM, WaringRH, HughesPJ: Do dietary phytoestrogens influence susceptibility to hormone-dependent cancer by disrupting the metabolism of endogenous oestrogens?Biochem. Soc. Trans.29, 209–216 (2001).
   PubMed Web of Science ®Google Scholar
• Makela S , PoutanenM, LehtimakiJ, KostianML, SanttiR, VihkoR: Oestrogen-specific 17b-hydroxysteroidoxido reductase type 1 [E.C. 1.1.162] as a possible target for the action of phytoestrogens.Proc. Soc. Exp. Biol. Med.208, 51–59 (1995).
   PubMed Web of Science ®Google Scholar
• Makela S , PoutanenM, KostianMLet al.: Inhibition of 17b-hydroxysteroid oxidoreductase by flavonoids in breast and prostate cancer cells. Proc. Soc. Exp. Biol. Med.217, 310–316 (1998).
   PubMed Web of Science ®Google Scholar
• Knight DC , EdenJA: A review of the clinical effects of phytoestrogens.Obstet. Gynecol.87, 897–904 (1996).
   PubMed Web of Science ®Google Scholar
• Earp HS , CalvoBF, SartorCI: The EGF receptor family–multiple roles in proliferation, differentiation and neoplasia with an emphasis on HER 4.Trans. Am. Clin. Climatol. Assoc.114, 315–333 (2003).
   PubMedGoogle Scholar
• Normanno N , BiancoC, De LucaA, MaielloMR, SalomonDS: Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment. Endocr. Relat. Cancer10, 1–21 (2003).
   PubMed Web of Science ®Google Scholar
• Vogel CL , CobleighMA, TripathyDet al.: First-line herceptin monotherapy in metastatic breast cancer. Oncology61, 37–42 (2001).
   PubMed Web of Science ®Google Scholar
• Uckun FM , NarlaRK, JunXet al.: Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells. Clin. Cancer Res.4, 901–912 (1998).
   PubMed Web of Science ®Google Scholar
• Uckun FM , NarlaRK, ZerenTet al.: In vivo toxicity, pharmacokinetics and anticancer activity of Genistein linked to recombinant human epidermal growth factor. Clin. Cancer Res.4, 1125–1134 (1998b).
   PubMed Web of Science ®Google Scholar
• Chen CL , LevineA, RaoAet al.: Clinical pharmacokinetics of the CD19 receptor-directed tyrosine kinase inhibitor B43-Genistein in patients with B-lineage lymphoid malignancies. J. Clin. Pharmacol.39, 1248–1255 (1999).
   PubMed Web of Science ®Google Scholar
• Huynh H , NguyenTT, ChanE, TranE: Inhibition of ErbB-2 and ErbB-3 expression by quercetin prevents transforming growth factor a (TGF-α) – and epidermal growth factor (EGF)-induced human PC-3 prostate cancer cell proliferation.Int. J. Oncol.23, 821–829 (2003).
   PubMed Web of Science ®Google Scholar
• Kaneuchi M , SasakiM, TanakaY, SakuragiN, FujimotoS, DahivaR: Quercetin regulates the growth of Ishikawa cells through the suppression of EGF and cyclin D1. Int. J. Oncol.22, 159–164 (2003).
   PubMed Web of Science ®Google Scholar
• Richter M , EbermannR, MarianB: Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling.Nutr. Cancer34, 88–99 (1999).
   PubMed Web of Science ®Google Scholar
• Lee LT , HuangYT, HwangJJet al.: Blockade of the epidermal growth factor receptor kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res.22, 1615–1627 (2002).
   PubMed Web of Science ®Google Scholar
• Huang YT , HwangJJ, LeePPet al.: Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastases-associated properties in A41 cells overexpressing epidermal growth factor receptor. Br. J. Pharmacol.128, 999–1010 (1999).
   PubMed Web of Science ®Google Scholar
• McIntyre BS , SylvesterPW: Genistein and erbstatin inhibition of normal mammary epithelial cell proliferation is associated with EGF-receptor down-regulation.Cell. Prolif.31, 35–46 (1998).
   PubMed Web of Science ®Google Scholar
• Smith GH : TGF-β and functional differentiation.J. Mammary Gland Biol. Neoplasia1, 343–352 (1996).
   PubMed Web of Science ®Google Scholar
• Kretzschmar M : Transforming growth factor-β and breast cancer: transforming growth factor-β/SMAD signaling defects and cancer.Breast Cancer Res.2, 107–115 (2000).
   PubMed Web of Science ®Google Scholar
• Yu Z , TangY, HuD, LiJ: Inhibitory effect of genistein on mouse colon cancer MC-26 cells involved TGF-β1/Smad.Biochem. Biophys. Res. Commun.333, 827–832 (2005).
   PubMed Web of Science ®Google Scholar
• Korzenik JR , BarnesS, WhiteRIJr Possible efficacy of isolated soy protein in treatment of hereditary hemorrhagic telangiectasia-associated epistaxis, gastrointestinal hemorrhage and migraine; a pilot study. Am. J. Clin. Nutr.68, Abstract 1530S (1998).
   Web of Science ®Google Scholar
• Scambia G , PaniciPB, RanellettiFOet al.: Quercetin enhances transforming growth factor β 1 secretion by human ovarian cancer cells. Int. J. Cancer57, 211–215 (1994).
   PubMed Web of Science ®Google Scholar
• Larocca LM , TeofiliL, SicaSet al.: Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-beta 1 in these cells. Blood85, 3654–3661 (1995).
   PubMed Web of Science ®Google Scholar
• Lee JS , SonKH, SungMK, KimYK, YuR, KimJS: Anticarcinogenic properties of a daidzein-rich fraction isolated from soybean.J. Med. Food Fall.6, 175–181 (2003).
   PubMedGoogle Scholar
• Phan TT , LimIJ, ChanSY, TanEK, LeeST, LongakerMT: Suppression of transforming growth factor beta/smad signaling in keloid-derived fibroblasts by quercetin: implications for the treatment of excessive scars.J. Trauma57, 1032–1037 (2004).
   PubMed Web of Science ®Google Scholar
• Nakaya M , TachibanaH, YamadaK: Isoflavone genistein and daidzein up-regulate LPS-induced inducible nitric oxide synthase activity through estrogen receptor pathway in RAW264.7 cells.Biochem. Pharmacol.71, 108–114 (2005).
   PubMed Web of Science ®Google Scholar
• Jun M , HongJ, JeongWS, HoCT: Suppression of arachidonic acid metabolism and nitric oxide formation by kudzu isoflavones in murine macrophages.Mol. Nutr. Food Res.49, 1154–1159 (2005).
   PubMed Web of Science ®Google Scholar
• Mahn K , BorrasC, KnockGAet al.: Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo. FASEB J.19, 1755–1757 (2005).
   PubMed Web of Science ®Google Scholar
• Simoncini T , FornariL, MannellaPet al.: Activation of nitric oxide synthesis in human endothelial cells by red clover extracts. Menopause12, 69–77 (2005).
   PubMed Web of Science ®Google Scholar
• Hsu JT , YingC, ChenCJ: Regulation of inducible nitric oxide synthase by dietary phytoestrogen in MCF-7 human mammary cancer cells.Reprod. Nutr. Dev.40, 11–18 (2000).
   PubMedGoogle Scholar
• Sun S , ZhaoX, ZhaoL: Effects of genistein on NOS, GSH-Px activities and NO, GSH, MDA contents in MCF human breast cancer cells.Wei Sheng Yan Jiu33, 468–469 (2004).
   PubMedGoogle Scholar
• Kanashiro CA , KhalilRA: Signal transduction by protein kinase C in mammalian cells.Clin. Exp. Pharmacol. Physiol.25, 974–985 (1998).
   PubMed Web of Science ®Google Scholar
• Kempuraj D , MadhappanB, ChristodoulouSet al.: Flavonols inhibit proinflammatory mediator release, intracellular calcium ion levels and protein kinase C τ phosphorylation in human mast cells. Br. J. Pharmacol.145, 934–944 (2005).
   PubMed Web of Science ®Google Scholar
• Zhang XM , ChenJ, XiaYG, XuQ: Apoptosis of murine melanoma B16-BL6 cells induced by quercetin targeting mitochondria, inhibiting expression of PKC-α and translocating PKC-δ.Cancer Chemother. Pharmacol.55, 251–262 (2005).
   PubMed Web of Science ®Google Scholar
• Russo M , PalumboR, MupoAet al.: Flavonoid quercetin sensitizes a CD95-resistant cell line to apoptosis by activating protein kinase C alpha. Oncogene22, 3330–3342 (2003).
   PubMed Web of Science ®Google Scholar
• Yoshida M , YamamotoM, NikaidoT: Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle.Cancer Res.52, 6676–6681 (1992).
   PubMed Web of Science ®Google Scholar
• Sherr CJ , RobertsJM: CDK inhibitors: positive and negative regulators of G1 phase progression.Gen. Dev.13, 1501–1512 (1999).
   PubMed Web of Science ®Google Scholar
• Aguero MF , FacchinettiMM, ShelegZ, SenderowiczAM: Phenoxodiol, a novel isoflavone, induces G1 arrest by specific loss in cyclin-dependent kinase 2 activity by p53-independent induction of p21WAF1/CIP1.Cancer Res.65, 3364–3373 (2005).
   PubMed Web of Science ®Google Scholar
• Chang KL , KungML, ChowNH, SuSJ: Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee 1.Biochem. Pharmacol.67, 717–726 (2004).
   PubMed Web of Science ®Google Scholar
• Choi YH , ZhangL, LeeWH, ParkKY: Genistein-induced G2/M arrest is associated with the inhibition of cyclin B1 and the induction of p21 in human breast carcinoma cells.Int. J. Oncol.13, 391–396 (1998).
   PubMed Web of Science ®Google Scholar
• Frey RS , LiJ, SingletaryKW: Effects of genistein on cell proliferation and cell cycle arrest in nonneoplastic human mammary epithelial cells: involvement of Cdc2, p21(waf/cip1), p27(kip1), and cdc25C expression.Biochem. Pharmacol.61, 979–989 (2001).
   PubMed Web of Science ®Google Scholar
• Kobayashi T , NakataT, KuzumakiT: Effect of flavonoids on cell cycle progression in prostate cancer cells.Cancer Lett.176, 17–23 (2002).
   PubMed Web of Science ®Google Scholar
• Vijayababu MR , KanagarajP, ArunkumarA, IlangovanR, AruldhasMM, ArunakaranJ: Quercetin-induced growth inhibition and cell death in prostatic carcinoma cells (PC-3) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression.J. Cancer Res. Clin. Oncol.131, 765–771 (2005).
   PubMed Web of Science ®Google Scholar
• Cappelletti V , FioravantiL, MiodiniP, Di FronzoG: Genistein blocks breast cancer cells in the G(2) M phase of the cell cycle. J. Cell Biochem.79, 594–600 (2000).
   PubMed Web of Science ®Google Scholar
• Balabhadrapathruni S , ThomasTJ, YurkowEJ, AmentaPS, ThomasT: Effects of genistein and structurally related phytoestrogens on cell cycle kinetics and apoptosis in MDA-MB-231 human breast cancer cells. Oncol. Rep.7, 3–12 (2000).
   PubMed Web of Science ®Google Scholar
• Kishimoto T , OkumuraE: In vivo regulation of the entry into M-phase: initial activation and nuclear translocation of cyclin B/Cdc2.Prog. Cell Cycle Res.3, 241–249 (1997).
   PubMedGoogle Scholar
• Choi JA , KimJY, LeeJYet al.: Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int. J. Oncol.19, 837–844 (2001).
   PubMed Web of Science ®Google Scholar
• Handayani R , RiceL, CuiYet al.: Soy isoflavones alter expression of genes associated with cancer progression including interleukin-8, in androgen-independent PC-3 human prostate cancer cells. J. Nutr.136, 75–82 (2006).
   PubMed Web of Science ®Google Scholar
• Vissac-Sabatier C , BignonYJ, Bernard-GallonDJ: Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell lines.Nutr. Cancer45, 247–255 (2003).
   PubMed Web of Science ®Google Scholar
• Caetano B , Le CorreL, ChalabiN, DelortL, BignonYJ, Bernard-GallonDJ: Soya phytonutrients act on a panel of genes implicated with BRCA1 and BRCA2 oncosuppressors in human breast cell lines. Br. J. Nutr.95, 406–413 (2006).
   PubMed Web of Science ®Google Scholar
• O‘Toole SA , SheppardBL, SheilsO, O‘LearyJJ, SpenglerB, ChristoffelV: Analysis of DNA in endometrial cancer cells treated with phyto-estrogenic compounds using comparative genome hybridization microarrays.Planta Med.71, 435–439 (2005).
   PubMed Web of Science ®Google Scholar
• Ramanathan L , GrayWG: Identification and characterization of a phytoestrogen-specific gene from the MCF-7 human breast cancer cell.Toxicol. Appl. Pharmacol.191, 107–117 (2003).
   PubMed Web of Science ®Google Scholar
• Willard ST , FrawleyLS: Phytoestrogens have agonistic and combinatorial effects on estrogen-responsive gene expression in MCF-7 human breast cancer cells.Endocrine8, 117–121 (1998).
   PubMed Web of Science ®Google Scholar
• Fotsis T , PepperMS, MontesanoRet al.: Phytoestrogens and inhibition of angiogenesis. Baillieres Clin. Endocrinol. Metab.12, 649–666 (1998).
   PubMed Web of Science ®Google Scholar
• Kiriakidis S , HogemeierO, StarckeSet al.: Novel tempeh (fermented soyabean) isoflavones inhibit in vivo angiogenesis in the chicken chorioallantoic membrane assay. Br. J. Nutr.93, 317–323 (2005).
   PubMed Web of Science ®Google Scholar
• Zhou JR , MukherjeeP, GuggerET, YanakaT, BlackburnGL, ClintonSK: Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis and angiogenesis. Cancer Res.58, 5231–5238 (1998).
   PubMed Web of Science ®Google Scholar
• Igura K , OhtaT, KurodaY, KajiK: Resveratrol and quercetin inhibit angiogenesis in vitro.Cancer Lett.171, 11–16 (2001).
   PubMed Web of Science ®Google Scholar
• Dabrosin C , ChenJ, WangL, ThompsonLU: Flaxseed inhibits metastasis and decreases extracellular vascular endothelial growth factor in human breast cancer xenografts. Cancer Letts185, 31–37 (2002).
   PubMed Web of Science ®Google Scholar
• Whatmore JL , SwannE, BarrajaPet al.: Comparative study of isoflavone, quinoxaline and oxindole families of anti-angiogenic agents. Angiogenesis5, 45–51 (2002).
   PubMedGoogle Scholar
• Tan WF , LinLP, LiMHet al.: Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential. Eur. J. Pharmacol.459, 255–262 (2003).
   PubMed Web of Science ®Google Scholar
• Yu XP , MiMT, ZhuJD: Effect of genistein on expression of angiogenesis related factors in HER-2/neu-overexpressing breast cancer cells.Shi Yan Sheng Wu Xue Bao37, 251–253 (2004).
   PubMedGoogle Scholar
• Armand JP , CunninghamD, van CutsemE, MissetJL, KhoneCH: Clinical advances with topoisomerase I inhibitors in gastrointestinal malignancies. Anticancer Drugs (10 Suppl. 1), S5–S12 (1999).
   PubMed Web of Science ®Google Scholar
• Boege F , StraubT, KehrAet al.: Selected novel flavones inhibit the DNA binding or the DNA relegation step of eukaryotic topoisomerase I. J. Biol. Chem.271, 2262–2270 (1996).
   PubMed Web of Science ®Google Scholar
• Schoeffler AJ , BergerJM: Recent advances in understanding structure-function relationships in the type II topoisomerase.Biochem. Soc. Trans.33, 1465–1470 (2005).
   PubMed Web of Science ®Google Scholar
• Denny WA : Emerging DNA topoisomerase inhibitors as anticancer drugs.Expert Opin. Emerg. Drugs9, 105–133 (2004).
   PubMedGoogle Scholar
• Fortune JM , OsheroffN: Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice.Prog. Nucleic Acid Res. Mol. Biol.64, 221–253 (2000).
   PubMed Web of Science ®Google Scholar
• Constantinou A , MehtaR, RunyanC, RaoK, VaughanA, MoonR: Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships. J. Nat. Prod.58, 217–225 (1995).
   PubMed Web of Science ®Google Scholar
• McCabe MJ Jr , OrreniusS Genistein induces apoptosis in immature human thymocytes by inhibiting topoisomerase-II. Biochem. Biophys. Res. Commun.194, 944–950 (1993).
   PubMed Web of Science ®Google Scholar
• Markovits J , LinassierC, FossePet al.: Inhibitory effects of tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res.49, 5111–5117 (1989).
   PubMed Web of Science ®Google Scholar
• Chowdhury AR , SharmaS, MandalS, GoswamiA, MukhopadhyayS, MajumderHK: Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase. Biochem. J.366, 653–661 (2002).
   PubMed Web of Science ®Google Scholar
• Constantinou AI , HusbandA: Phenoxodiol (2H-1-benzopyran-7–0,1,3-[4-hydroxyphenyl]), a novel isoflavone derivative, inhibits DNA topoisomerase II by stabilizing the cleavable complex.Anticancer Res.22, 2581–2585 (2002).
   PubMed Web of Science ®Google Scholar
• Azuma Y , OnishiY, SatoY, KizakiH: Effects of protein tyrosine kinase inhibitors with different modes of action on topoisomerase activity and death of IL-2-dependent CTLL-2 cells.J. Biochem.118, 312–318 (1995).
   PubMed Web of Science ®Google Scholar
• Yamashita Y , KawadaS, NakanoH: Induction of mammalian topoisomerase II dependent cleavage by nonintercalative flavonoids, genistein and orobol.Biochem. Pharmacol.39, 737–744 (1990).
   PubMed Web of Science ®Google Scholar
• Austin CA , PatelS, OnoK, NakaneH, FisherLM: Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives.Biochem. J.282, 883–889 (1992).
   PubMed Web of Science ®Google Scholar
• Bernard FX , SableS, CameronBet al.: Glycosylated flavones as selective inhibitors of topoisomerase IV. Antimicrob. Agents Chemother.41, 992–998 (1997).
   PubMed Web of Science ®Google Scholar
• Chen YC , SuriyamaY, AbeN, Kuruto-NiwaR, NozawaR, HirotaA: DPPH radical-scavenging compounds from dou-chi, a soybean fermented food. Biosci. Biotechnol. Biochem.69, 999–1006 (2005).
   PubMed Web of Science ®Google Scholar
• Thompson LU : Antioxidants and hormone-mediated health benefits of whole grains.Crit. Rev. Food Sci. Nutr.34, 473–497 (1994).
   PubMed Web of Science ®Google Scholar
• Woodside JV , CampbellMJ, DenholmEEet al.: Short-term phytoestrogen supplementation alters insulin-like growth factor profile but not lipid or antioxidant status. J. Nutr. Biochem.17, 211–215 (2006).
   PubMed Web of Science ®Google Scholar
• Yu Z , ZhangL, WuD: Genistein induced apoptosis in MCF-7 and T47D cells.Wei Sheng Yan Jiu32, 125–127 (2003).
   PubMedGoogle Scholar
• Rossi T , CastelliM, ZandomeneghiGet al.: Selectivity of action of glycyrrhizin derivatives on the growth of MCF-7 and HEP-2 cells. Anticancer Res.23, 3813–3818 (2003).
   PubMed Web of Science ®Google Scholar
• Nomoto S , AraoY, HoriguchiH, IkedaK, KayamaF: Oestrogen causes G2/M arrest and apoptosis in breast cancer cells MDA-MB-231.Oncol. Rep.9, 773–776 (2002).
   PubMed Web of Science ®Google Scholar
• Totta P , AcconicaF, VirgiliFet al.: Daidzein-sulfate metabolites affect transcriptional and antiproliferative activities of estrogen receptor-β. J. Nutr.135, 2687–2693 (2005).
   PubMed Web of Science ®Google Scholar
• Signorelli P , GhidoniR: Resveratol as an anticancer nutrient: molecular basis, open questions and promises.J. Nutr. Biochem.16, 449–466 (2005).
   PubMed Web of Science ®Google Scholar
• Rafi MM , RosenRT, VassilAet al.: Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid. Anticancer Res.20, 2653–2658 (2000).
   PubMed Web of Science ®Google Scholar
• Hargreaves DF , PottenCS, HardingCet al.: Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast. J. Clin. Endocrinol. Metab.84, 4017–4024 (1999).
   PubMed Web of Science ®Google Scholar
• Schmidt S , MichnaH, DielP: Combinatory effects of phytoestrogens and 17β-estradiol on proliferation and apoptosis in MCF-7 breast cancer cells.J. Steroid Biochem. Mol. Biol.94, 445–449 (2005).
   PubMed Web of Science ®Google Scholar
• Cooke PS , SelvarajV, YellayiS: Genistein, estrogen receptors, and the acquired immune response.J. Nutr.136, 704–708 (2006).
   PubMed Web of Science ®Google Scholar
• Guo TL , ChiRP, GermolecDR, WhiteKL: Stimulation of the immune response in B6C3F1 mice by genistein is affected by exposure, duration, gender and litter order.J. Nutr.135, 2449–2456 (2005).
   PubMed Web of Science ®Google Scholar
• Yellayi S , NaazA, SzewczykowskiMAet al.: The phytoestrogen genistein induces thymic and immune changes: a human health concern?Proc. Natl Acad. Sci. USA99, 7616–7621 (2002).
   PubMed Web of Science ®Google Scholar
• Yellayi S , ZakroczymskiMA, SelvarajVet al.: The phytoestrogen genistein suppresses cell-mediated immunity in mice. J. Endocrinol.176, 267–274 (2003).
   PubMed Web of Science ®Google Scholar
• Zhang R , LiY, WangW: Enhancement of immune function in mice fed high doses of soy daidzein.Nutr. Cancer29, 24–28 (1997).
   PubMed Web of Science ®Google Scholar
• Stopper H , SchmittE, KobrasK: Genotoxicity of phytoestrogens.Mutat. Res.574, 139–155 (2005).
   PubMed Web of Science ®Google Scholar
• Kulling SE , MetzlerM: Induction of micronuclei, DNA strand breaks and HPRT mutations in cultured Chinese hamster V79 cells by the phytoestrogen coumestrol.Food Chem. Toxicol.35, 605–613 (1997).
   PubMed Web of Science ®Google Scholar
• Mitchell JH , DuthrieSJ, CollinsAR: Effects of phytoestrogens on growth and DNA integrity in human prostate tumor cell lines PC-3 and LNCaP.Nutr. Cancer38, 223–228 (2000).
   PubMed Web of Science ®Google Scholar
• Boos G , StopperH: Genotoxicity of several clinically used topoisomerase II inhibitors.Toxicol. Letts116, 7–16 (2000).
   PubMed Web of Science ®Google Scholar
• Tsutsui T , TamuraY, YagiEet al.: Cell-transforming activity and mutagenicity of 5 phytoestrogens in cultured mammalian cells. Int. J. Cancer105, 312–320 (2003).
   PubMed Web of Science ®Google Scholar
• Chen YC , InabaM, AbeN, HirotaA: Antimutagenic activity of 8-hydroxyisoflavones and 6-hydroxydaidzein from soybean miso.Biosci. Biotechnol. Biochem.67, 903–906 (2003).
   PubMed Web of Science ®Google Scholar
• Miyazawa M , SakanoK, NakamuraS, KosakaH: Antimutagenic activity of isoflavones from soybean seeds (Glycine max Merrill). J. Agric. Food Chem.47, 1346–1349 (1999).
   PubMed Web of Science ®Google Scholar
• Puli S , LaiJC, BhushanA: Inhibition of matrix degrading enzymes and invasion in human glioblastoma (U87MG) cells by isoflavones.J. Neurooncol.79, 135–142 (2006).
   PubMed Web of Science ®Google Scholar
• Moshal KS , SenU, TyagiNet al.: Regulation of homocysteine-induced MMP-9 by ERK1/2 pathway. Am. J. Physiol. Cell Physiol.290, C883–C891 (2006).
   PubMed Web of Science ®Google Scholar
• Talavera D , CastilloAM, DominguezMC, GutierrezAE, MezaI: IL8 release, tight junction and cytoskeleton dynamic reorganization conducive to permeability increase are induced by dengue virus infection of microvascular endothelial monolayers.J. Gen. Virol.85, 1801–1813 (2004).
   PubMed Web of Science ®Google Scholar
• Cirone M , ZompettaC, TarasiD, FratiL, FaggioniA: Infection of human T lymphoid cells by human herpesvirus 6 is blocked by two unrelated protein tyrosine kinase inhibitors, biochanin A and herbimycin.AIDS Res. Hum. Retroviruses12, 1629–1634 (1996).
   PubMed Web of Science ®Google Scholar
• Fesen MR , KohnKW, LeteurtreF, PommierY: Inhibitors of human immunodeficiency virus integrase. Proc. Natl Acad. Sci. USA90, 2399–2403, (1993).
   PubMed Web of Science ®Google Scholar
• Martin JHJ , CrottyS, WarrenP, NelsonPN: Does an apple a day keep the doctor away because a phytoestrogen a day keeps the virus at bay? A review of the anti-viral properties of phytoestrogens.Phytochemistry68, 266–274 (2007).
   PubMed Web of Science ®Google Scholar
• Nelson PN , HooleyP, RodenDet al.: Human endogenous retroviruses: transposable elements with potential?Clin. Exp. Immunol.138, 1–9 (2004).
   PubMed Web of Science ®Google Scholar
• Nelson PN , CarnegiePR, MartinJet al.: Demystified. Human endogenous retroviruses. Mol. Pathol.56, 11–18 (2003).
   PubMedGoogle Scholar
• Larsson E , AnderssonG: Beneficial role of human endogenous retroviruses: facts and hypotheses.Scand. J. Immunol.48, 329–338 (1998).
   PubMed Web of Science ®Google Scholar
• Yi JM , KimHM, KimHS: Expression of the human endogenous retrovirus HERV-W family in various human tissues and cancer cells.J. Gen. Virol.85, 1203–1210 (2004).
   PubMed Web of Science ®Google Scholar
• Martin JHJ , CrottyS, WarrenP, NelsonP: The effect of phytoestrogens on nitric oxide production and HERV-K10 expression of human breast cancer cell lines. Abstracts of the National Cancer Research Institute Cancer Conference. Birmingham, UK, 2–5 October (2005) (Abstract P66).
   Google Scholar
• Divi RL , DoergeDR: Inhibition of thyroid peroxidase by dietary flavonoids.Chem. Res. Toxicol.9, 16–23 (1996).
   PubMed Web of Science ®Google Scholar
• Pocas ES , CostaPR, da SilvaAJ, NoelF: 2-Methoxy-3,8,9-trihydroxy coumestan: a new synthetic inhibitor of Na+,K+ATPase with an original mechanism of action. Biochem. Pharmacol.66, 2169–2176 (2003).
   PubMed Web of Science ®Google Scholar
• Vera JC , ReyesAM, CarcamaoJGet al.: Genistein is a natural inhibitor of hexose and dehydroascorbic acid transport through the glucose transporter GLUT1. J. Biol. Chem.271, 8719–8724 (1996).
   PubMed Web of Science ®Google Scholar
• Cassidy A : Factors affecting the bioavailability of soy isoflavones in humans.J. AOAC Int.89, 1182–1188 (2006).
   PubMed Web of Science ®Google Scholar
• Manach C , WilliamsonG, MorandC, ScalbertA, RemesyC: Bioavailability and bioefficacy of polyphenols in humans I. Review of 97 bioavailability studies.Am. J. Clin. Nutr.81, 230S–242S (2005).
   PubMed Web of Science ®Google Scholar

Websites

• US Department of Agriculture, Agricultural Research Service. 2006 USDA–Database for the Flavonoid Content of Selected Foods, Release 2- 2006 Nutrient Data Laboratory website. www.nal.usda.gov/fnic/foodcomp/Data/Flav/Flav02.pdf
   Google Scholar
• US Department of Agriculture, Agricultural Research Service. 2002. USDA–Iowa State University Database on the Isoflavone Content of Foods, Release 1.3 -2002. Nutrient Data Laboratory website. www.nal.usda.gov/fnic/foodcomp/Data/isoflav/isoflav.html
   Google Scholar
• Second expert report on food, nutrition, physical activity and the prevention of cancer: a global perspective. www.aicr.org/site/PageServer?pagename=wcrf_reportexpectu&JServSess
   Google Scholar
• Committee on Toxicity Report- Phytoestrogens and Health (2003). www.food.gov.uk/science/ouradvisors/toxicity/COTwg/wg_phyto/
   Google Scholar